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Abstract
Introduction. Chromosomal changes are widespread in the vast majority of colon carcinomas and aneuploidy is 
an established prognostic factor. However, this knowledge so far has no influence on tumor classification. We 
reported a morphology-based classification scheme, the core classification, that correlates with DNA ploidy. In 
particular, tripolar mitoses were identified as surrogate markers of a near triploid DNA content. In addition, 
a survey on chromosome numbers and survival rates in carcinomas suggested that triploidy as a particular state 
of aneuploidy may be correlated with a more aggressive tumor phenotype. We therefore aimed to analyse DNA 
ploidy in the colorectal adenoma–carcinoma sequence. 
Material and methods. The study collection consisted of 15 adenomas and 15 adenocarcinomas of 10 patients. 
Some of them showed a morphological transition between benign and malignant tumor components which were 
selectively analysed by DNA measurements. In addition, we assessed the morphological parameters of the core 
classification. 
Results. The main findings of the study may be summarized as follows. 1) DNA ploidy changes are already 
consistently detectable in colon adenomas. They are usually associated with hyperdiploidy. 2) Adenoma tissue 
adjacent to carcinomas, however, may carry a hypodiploid DNA content while the nearby carcinoma samples 
were hyperdiploid. Hypodiploidy may thus represent a transition state to near triploid carcinomas. 3) The size 
of tumor nuclei and mitoses usually reflects the ploidy level of colon tumors. Specifically, triploid mitoses may 
point to a near triploid DNA content. 4) Triploidy per se cannot be equated with tumor aggressiveness as it 
may already be found in adenocarcinoma in situ. 5) Tripolar and tetrapolar mitoses in invasive colon cancer, 
however, are potential indicators of an advanced chromosomal instability and seemed to be associated with 
advanced tumor stages.
Conclusions. We present data that hypodiploidy may represent a transition state from adenoma to carcinoma 
in a subset of colorectal tumors and that near-triploidy may be associated with a more aggressive course of the 
disease. However, the interpretation of tripolar mitoses and triploidy is largely dependent on the cell type (be-
nign vs. malignant) and tissue context (invasive vs. non-invasive cancer). Furthermore, its interpretation may 
be distinct for different tumor stages and histotypes. Aneuploidy and multipolar mitoses are frequent findings 
in cancer cells. Their relevance for tumor biology deserves further studies. (Folia Histochemica et Cytobiologica 
2015, Vol. 53, No. 1, 11–18)
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Introduction
Colorectal cancer is with one million new cases and 
with over 500,000 deaths per year the third most 
common cancer worldwide and a leading health prob- 
lem [1]. In 2008, 1.2 million new cases were diagnosed 
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and about 600,000 deaths were recorded [2]. In Germa-
ny, it is the second most frequent and also the second 
most deadly cancer type [3]. However, it can be treated 
to full recovery if diagnosed at an early stage [4].
Colon cancer comprises various types of tumors [5]. 
Approximately 70% of colon carcinomas develop 
from an adenoma. The adenoma–carcinoma sequence 
refers to the development of cancer in the context 
of a previous adenoma. The probability of develo-
ping cancer increases with an increased number of 
adenomas in the colon. Villous polyps in particular 
are considered high risk. The investigation in the 
St. Mark’s Hospital (London, UK) on 2506 patients 
revealed that tubular adenomas (75%) occur much 
more frequently than the villous adenomas (10%). 
With respect to malignancy, it was found that only 
4% of tubular adenomas but 40% of villous adenomas 
developed into carcinoma [6]. It may take about 
10 years for an adenomatous polyp to transform into 
cancer [7].
The growth pattern of colon adenomas is also an 
important feature in the definition of the degree of 
epithelial dysplasia which is usually divided into three 
degrees of severity (mild, moderate and severe) or 
two grades, i.e. low grade and high grade adenomas 
[5, 8]. The degree of epithelial dysplasia is related to 
the extent of aneuploidy in adenomas. In carcinomas, 
in contrast, there is no correlation between the degree 
of malignancy and aneuploidy [9].
The histological structure of a severe dysplasia is 
similar to a carcinoma in situ [10]. Adenomas with 
mild dysplasia develop only rarely into cancer and 
it has been reported that the size and the type of 
adenoma are related to the DNA aneuploidy. Ade-
nomas with a size smaller than 1 cm had no signs 
of aneuploidy. In contrast, larger adenomas had 
a significant increase in DNA aneuploidy and tubulo-
villous adenomas had the highest frequency of DNA 
changes [11].
The adenoma–carcinoma sequence is the morpho-
logical correlate of the meanwhile accepted fact that 
colon cancer is caused by the accumulation of genetic 
defects [12, 13]. Genomic instability has been consi-
dered the engine of tumorigenesis and specifically 
colorectal carcinoma development may be facilitated 
by genetic instability that can arise in the context of 
familial cancer syndromes [14].
It is important to note that in an early stage of 
cancer, there can be inactivation of the APC (adeno-
matous polyposis coli) gene, RAS mutation and loss 
of p53 [15]. Tumors are formed by a series of specific 
gene mutations and many more have been meanwhile 
reported [16, 17]. The oncogenic process is related to 
multiple pathways [16, 18]. In addition it is based on 
genomic instability which is generally associated with 
chromosomal changes [19]. The changes of the DNA 
content reflect the chromosomal changes which play 
an important role in tumorigenesis [20, 21]. DNA al-
terations can occur in adenomas, hyperplastic polyps, 
normal colon mucosa and ulcerative colitis even 
without dysplasia [5, 22, 23]. It has been suggested 
that aneuploidy is an early sign of carcinogenesis [22].
The aim of this study was to investigated the DNA 
content of colon tumors in the adenoma–carcinoma 
sequence.
Material and methods
Tumor collection. Tissue samples of 10 patients were used. 
They were diagnosed and treated at the Berlin Charité 
Hos pital and the Jena University Hospital between 2003 
and 2008. In total, the material consists of 15 adenomas and 
15 carcinomas. The study investigated at least one tumor 
and one adenoma from each patient. Specimens originated 
from 6 male and 4 female patients, several of them had 
multiple tumors. The patients were on average 63 years old 
spanning an age range of 50 to 78 years. Patient and sample 
characteristics are provided in Table 1. 
Light microscopic examination. In total, we analysed 
30 formalin-fixed and paraffin embedded tissue samples. The 
histopathological analysis was based on haematoxylin-eosin 
(H & E) stained 5 µm thick sections. The slides were eva-
luated morphologically according to the core classification 
which is based on cytomorphological criteria, in particular 
the size of the tumor nuclei and mitoses [24, 25]. In each 
slide at least 10 random fields were examined to judge at 
higher magnifications (× 200 and × 400) the predominant 
size of the tumor nuclei and their size variability. The nuclei 
sizes were classified on a scale ranging from small (score 1), 
medium (score 2), large (score 3) to giant (score 4) using 
non-tumor cells, in particular lymphocytes, as reference [24]. 
Also the mitosis size was classified in the same manner. In 
addition, the presence of tripolar and/or tetrapolar mitoses 
was recorded [24, 25]. All parameters are listed in Table 1.
Measurement of DNA content in cell nuclei stained by 
Feulgen method. To select for specific tumor areas, e.g. ade- 
noma adjacent to a carcinoma, two punches of tumor tissue 
of the size of 1.0 mm each were removed from the paraffin 
block. These tissue samples were deparaffinised with xy-
lene and rehydrated by passing through a graded series of 
alcohol concentrations. The material was then transferred 
to a 12 mL tube for the pepsin digestion (5 mL 0.07 M HCl 
supplemented by 25 mg pepsin, Serva, Germany, catalogue 
No. 31820) which was performed for around 90 min. The 
digestion was stopped by adding ice cold PBS buffer (5 mL 
PBS at 4°C). The cells were then centrifuged at 425 g for 
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10 min. About 6 to 8 mL of the supernatant was discarded 
and the cell nuclei were resuspended by mixing with a 1 mL 
pipette. The nuclei were then transferred onto adhesive glass 
slides (SuperFrost® Plus, Menzel-Gläser, Thermo Scienti-
fic) by applying 250 µL of the solution to a cyto-centrifuge 
(400 rpm, 10 min). Larger tissue debris was removed by prior 
filtration of the aliquot through a tissue Nylon biopsy bag 
(Shandon™ Nylon Biopsy Bags, Thermo Scientific). The 
Feulgen staining was performed after air drying the slides 
at room temperature on the following day as described 
earlier [24]. The Feulgen stain represents a classical dying 
method for DNA that yields purple stained nuclei. The 
preparations were finally covered by Vitro-Clud® (R. Lan-
genbrinck, Deutschland) and a cover slip (Menzel-Gläser, 
Thermo Scientific).
Static DNA cytometry was essentially performed as 
described earlier [24, 25]. Over 300 tumor cells nuclei as 
well as 30 reference non-tumor cells nuclei were manually 
selected. Lymphocytes and granulocytes were used as inter-
nal reference cells. The quality of the staining and measure-
Table 1. Study collective and results of DNA and morphological analysis
Clinicopathological data DNA and morphological data
Case Sex Age T-No. Diagnosis TNM Stage Grade Ploidy C size C var M size M var tri M tetra M
1 Male 70 1* ADC pT1, pN0 I G2 2,30c 1 3 1 2 No No
2* AD High 2,32c 1 3 1 2 No No
3 AD Low 2,43c 1 2 1 2 No No
4 AIS pTis G2 3,20c 2 4 2 3 Yes No
2 Female 54 5 ADC pT1, pN0 I G2 2,42c 1 2 2 2 No No
6 AD Low 2,49c 1 2 2 2 No No
7 AD Low 2,40c 1 2 1 2 No No
8 AD Low 2,17c 1 2 1 2 No No
3 Male 71 9 AD Low 2,40c 1 2 1 2 No No
10 AIS pTis G 3–4 3,44c 1 2 2 2 No No
11 ADC pT1, pN0 I G3 2,43c 2 2 1 2 No No
4 Male 76 12 ADC pT3, pN0 II G2 3,61c 2 4 3 3 No No
13 ADC pT3, pN0 II G2 2,20c 1 3 1 2 No No
14 AD Low 2,80c 1 2 1 3 No No
15 ADC pT3, pN0 II G2 2,51c 1 2 1 2 No No
16 AD Low 2,20c 1 3 2 3 No No
5 Male 78 17 ADC pT3, pN2 III G3 2,90c 1 3 2 3 Yes No
18 AD Low 2,20c 1 2 2 3 No No
6 Male 61 19* ADC pT1, pN0 I G2 2,39c 2 3 2 2 No No
20* AD High 2,60c 1 2 1 2 No No
21 AD Low 2,36c 1 2 2 2 No No
22* ADC pT1, pN0 I G2 2,57c 1 3 1 2 No No
23* AD High 2,20c 1 2 1 0 No No
7 Female 55 24* ADC pT3, pN2, M1 III G3 2,09c 2 4 2 2 No Yes
25* AD High 1,65c 2 4 2 2 No No
8 Male 50 26* ADC pT3, pN2 IV G3 2,13c 1 3 1 1 No Yes
27* AD High 1,75c 1 2 1 1 No No
9 Female 52 28* ADC pT1, pN1 III G3 3,05c 2 4 2 2 Yes No
29* AD High 1,75c 1 2 1 1 No No
10 Female 70 30 ADC pT1, pN0 I G2 3,60c 2 3 3 3 No No
*adenoma and adenocarcinoma sample adjacent to each other with morphological transition. Abbreviations: AD — adenoma; ADC — adeno-
carcinoma; AIS — adenocarcinoma in situ; T-No. — tumor sample number; C size — nuclear/core size; C var — core size variability; M size — 
mitosis size; M var — mitosis size variability; tri M — tripolar mitosis; tetra M — tetrapolar mitosis
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ments were validated by the manufacturer of the cytometry 
system, Dr. Olaf Ahrens. By comparing the reference cells 
with the cells of interest, a histogram was created (Figure 1). 
Based on the histogram and the evaluated parameters the 
DNA content and the ploidy status of the tumor cells were 
assessed (Table 1). 
The samples were measured with an ICM cytometry 
system (Dr. Olaf Ahrens, Bargteheide, Germany). This is 
a unit consisting of a Nikon microscope linked to a CCD-
-camera and a computer software that is able to assess the 
DNA content of cell nuclei. It relies on the measurement 
of the optical density of the Feulgen-stained nuclei [26]. 
Different parameters, such as the colour concentration of 
the cell nuclei, size of the nucleus and the ploidy of each 
tumor cell could be determined by the DNA cytometry 
system (Table 1).
Results
Clinicopathological analysis
Overall, we analysed 30 samples divided into 15 ade-
nomas and 15 carcinomas from 10 patients (Table 1). 
On the one hand special attention was taken to 
analyse carcinomas which morphologically had de-
veloped from adenomas, i.e. samples in which the 
adenoma–carcinoma-sequence was evident (cases 1, 
6, 7, 8, 9). On the other hand, we analysed samples 
Figure 1. Morphology and DNA ploidy of a colon adenoma and adenocarcinoma. A, B. Morphology of an adenoma (case 6,  
sample 21; H & E, magnification × 200) and an adenocarcinoma (case 5, sample 17; H & E, magnification × 630), 
respectively. The tripolar mitosis of the carcinoma (B, see arrow) was associated with a near triploid DNA content of the 
tumor cells (2,9c, see Table 1); C, D. DNA ploidy analysis of an adenoma and its adjacent adenocarcinoma, respectively. 
The adenoma carried a hypodiploid DNA content (case 9, sample 29, Table 1) while the adenocarcinoma (case 9, sample 
28, Table 1) showed a near triploid DNA ploidy state which suggests that the transition to malignancy was accompanied 
by a duplication of the hypodiploid chromosomal complement
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of adenomas and carcinomas from the same patient 
in which there were no morphological signs of a step
-wise transition between the benign and malignant 
tumor stage (cases 1, 2, 3, 4, 5, 6). Furthermore, in 
some of these cases several distinct carcinoma and 
adenoma samples were evaluated either because of 
multiple tumor formations (cases 3, 4, 6) or because 
morphological distinct tumor areas were detectable 
(case 4). In one case, a single carcinoma sample was 
investigated (case 10). With respect to the histotype, 
all carcinomas had typical intestinal type morphology 
except for one case with a signet ring cell carcinoma 
(case 4, tumor samples 13 and 15). Two carcinomas 
were in an early stage (in situ) while all other cancers 
represented invasive carcinomas (Table 1). 
The core classification of adenomas  
and adenocarcinomas
The core classification provided semi-quantitative 
parameters for the morphological analysis of the 
tumor samples (Table 1). There was no obvious cor-
relation between the morphology parameters (core 
size, mitosis size and their size variability) and tumor 
stage, e.g. sample 30 of a stage I tumor had increased 
size and variability parameters. However, there was 
a correlation between the presence of either tripolar 
or tetrapolar mitoses with advanced tumor stage. 
Four out of 5 tumors (samples 17, 24, 26, 28) were 
associated with stage III or IV disease while only 
one carcinoma in situ harboured a tripolar mitosis. 
Furthermore, tripolar mitoses were an indicator of 
a near triploid DNA content (samples 4, 17, 28). In 
addition, all carcinomas with increased DNA values 
(samples 4, 10, 12, 17, 28, 30) had also increased mor-
phology size values, which was particularly evident for 
the mitosis size. 
DNA ploidy status of adenomas  
and adenocarcinomas
The DNA content of the carcinomas ranged from 
2,09c to 3,61c with a mean DNA index of 2,59c. 
Thus, there was a considerable variation in the DNA 
content. Stage I carcinomas were mostly hyperdiploid 
ranging from 2,3c to 2,57c (samples 1, 5, 11, 19, 22) 
except for one tumor with a near tetraploid DNA 
content of 3,6c (sample 30). In stage II or higher cases 
(samples 12, 13, 15, 17, 24, 26, 28), there were more 
tumors with an increased DNA content. In particular, 
the only two carcinomas with lymph node metastases 
showed a near triploid DNA content of 2,9c and 3,05c 
respectively (samples 17 and 28). However, there 
was no clear relationship between the tumor stage 
and increased ploidy which is most obvious from the 
two carcinoma in situ cases (samples 4 and 10) which 
carried near triploid DNA contents of 3,2c and 3,44c, 
respectively. 
The DNA content in adenomas ranged from 1,65c 
to 2,80c with a mean DNA index of 2,3c. Interestingly, 
there were 3 adenomas adjacent to carcinomas with 
a hypodiploid DNA content (samples 25, 27, 29). 
Actually these initial cases prompted the initiation of 
the study. However, it was not a universal finding as 
two other adenomas with a transition to a carcinoma 
harboured hyperdiploid DNA values of 2,2c and 2,6c 
(samples 20 and 23). Most adenomas without signs 
of malignant transformation (samples 3, 6, 7, 8, 9, 18, 
21) had hyperdiploid DNA values ranging from 2,17c 
to 2,49c). The only exception was the adenoma of 
case 4, a patient with a distinct stage II cancer, which 
harboured tumor cells of near triploid DNA content 
of 2,80c (sample 14). 
Discussion
Chromosomal instability is a well-accepted charac-
teristic of colon cancer [27]. Similarly, DNA ploidy 
measurement has been established as a prognostic 
factor [28]. In addition, specific chromosomal imba-
lances have been associated with tumor behaviour 
[5, 29–31]. However, the detection of chromosomal 
imbalances by FISH or DNA ploidy measurement has 
not yet entered clinical practice which may be due to 
the fact that these changes seems to occur at an early 
phase of tumorigenesis [32]. 
We recently analysed the potential prognostic 
impact of the ploidy status of different cancer types 
by transforming the information on chromosomal 
changes of tumor karyotypes of the Mitelman data-
base into ploidy information [33]. The data suggested 
that a near triploid chromosomal content might be 
a criterion of more aggressive cancer types including 
colon carcinomas. In addition, we established a mor-
phology based classification, the core classification, 
which correlated with the ploidy level of cancer spe-
cimens [24, 25, 34]. The purpose of the present study 
was to evaluate these findings in colon carcinogenesis 
with specific attention to the adenoma–carcinoma 
sequence. 
The main results of the study may be summari-
zed as follows. 1) DNA ploidy changes are already 
consistently detectable in colon adenomas. They are 
usually associated with hyperdiploidy. 2) Adenoma 
tissue adjacent to carcinomas, however, may carry 
a hypodiploid DNA content while the nearby carcinoma 
samples were hyperdiploid. Hypodiploidy may thus 
represent a transition state to near triploid carcino-
16 Judith Staarmann et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2015
10.5603/FHC.a2015.0001
www.fhc.viamedica.pl
mas. 3) The size of tumor nuclei and mitoses usually 
reflects the ploidy level of colon tumors. Specifically, 
triploid mitoses may point to a near triploid DNA 
content. 4) Triploidy per se cannot be equated with 
tumor aggressiveness as it may already be found in 
adenoma or adenocarcinoma in situ. 5) Tripolar and 
tetrapolar mitoses in invasive colon cancer, however, 
are potential indicators of an advanced chromosomal 
instability and seemed to be associated with advanced 
tumor stages.
Steinbeck et al. and Ried et al. already reported 
chromosomal changes in colorectal adenomas [32, 35]. 
These studies indicated in particular the presence of 
DNA and chromosomal gains in early tumorigene-
sis. Our study suggested that hypodiploidy and thus 
chromosomal loss may occur in colon adenomas. This 
may be particularly relevant in those adenomas that 
have the propensity to progress to invasive carcinoma. 
We feel that this is a significant observation although 
it is difficult to judge the frequency and importance 
of it due to our limited number of cases. The loss of 
genetic material being potentially associated with 
the inactivation of tumor suppressor genes may play 
a similarly important role in tumor progression than 
the activation of oncogenes [27]. 
The study supports our previous notion that 
near-triploidy might serve as indicator for invasive 
carcinomas with a more aggressive phenotype [24, 33]. 
However, it must be stressed that the triploidy per se 
does not imply a simple yes or no distinction of the 
tumor behaviour as it may occur in benign tumors as 
well as adenocarcinoma in situ. In addition, it can be 
associated with hydatidiform mole, a pseudotumor 
formation of the uterus simulating pregnancy [36]. 
Thus, the interpretation of triploidy is strongly tissue 
and context dependent. There may be a subset of (non
-invasive) triploid lesions/tumors that behave in an 
indolent fashion. In invasive carcinoma, however, this 
genomic state seems to represent a form of chromo-
somal instability which favours tumor aggressiveness, 
thus representing an enabling hallmark of cancer [37]. 
Hypodiploidy may constitute a transition state 
to triploidy since the doubling of the chromosome 
content of a hypodiploid cell may yield a near triploid 
state. Similarly, the chromosomal splitting of a triplo-
id tumor cell does result in hypodiploidy which has 
been related to an unfavourable prognosis in acute 
lymphoblastic leukaemia and multiple myeloma [38, 
39, 40]. In carcinomas, there is also evidence for 
a prognostic influence of hypodiploidy. Specifically it 
has been shown that endometrioid carcinoma of the 
uterus bearing a good overall survival are generally 
hyperdiploid whereas the same tumor subtype in the 
ovary carrying a worse prognosis is usually hypodiplo-
id [41]. In addition, small cell lung cancer, the most 
aggressive pulmonary cancer subtype, is generally 
a hypodiploid tumor [24]. 
To our knowledge, the association of tripolar mi-
toses with a triploid DNA content was first described 
in normal rat cells [42]. It is frequently associated 
with octaploid cells that undergo divisions in which 
2 triploid cells and 1 diploid cell are generated (8n Æ 
3n + 3n + 2n). In normal cell, this does happen only 
very rarely. In contrast, it is a frequent event in cancer 
cells. The above equation is actually represented by 
the DNA histogram of carcinoma cells that usually 
show a minor diploid peak together with the major 
triploid one (Figure 1D). A similar observation was 
also made in lung cancer [24, 34]. 
While polyploidy in the liver has already been de-
scribed long time ago it has recently been shown that 
aneuploidy also occurs in normal human hepatocytes 
[43–45]. Polyploidy frequently represents a precu-
rsor state of aneuploidy [46, 47]. However, it is not 
a prerequisite for the development of aneuploidy [48]. 
Similarly, it is important to note that multipolar spindle 
formation and chromosome segregation defects are 
potential feature of non-neoplastic cells that do not 
necessarily result in cell death [44]. This is particularly 
true for cancer cells which have evolved sophisticated 
mechanisms to cope with frequently observed triploidy 
and tripolar mitoses [24, 33, 49].
In summary, the core classification of cancer be-
ing here applied for the first time to colon epithelial 
tumors provides information on the ploidy status of 
colon cancer and thus its chromosomal content. The 
study represents to our knowledge the first attempt to 
characterize the ploidy status of the adenoma–carci-
noma-sequence of colon cancer by analysing distinct 
areas from the same tumor of single patients by DNA 
cytometry. We present data that hypodiploidy may 
represent a transition state from adenoma to carci-
noma in a subset of tumors and that near-triploidy 
may be associated with a more aggressive course of 
the disease. However, the interpretation of tripolar 
mitoses and triploidy is largely dependent on the cell 
type (normal vs. cancer) and tissue context (invasive 
vs. non-invasive cancer). Furthermore, its interpreta-
tion may be distinct for different cancer histotypes. 
Aneuploidy and multipolar mitoses are frequent and 
relevant findings in cancer cells. Their features and 
impact for tumor biology deserves further studies. 
Acknowledgement
The technical and intellectual assistance of Dr. Olaf 
Ahrens in the DNA analysis of the colorectal tumor 
samples is gratefully acknowledged. 
17DNA ploidy in colorectal adenoma–carcinoma sequence
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2015
10.5603/FHC.a2015.0001
www.fhc.viamedica.pl
References
1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistic 
2002. CA Cancer J Clin. 2005;55:74–108. PMID: 15761078.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistic 2010. CA 
Cancer J Clin. 2010;60:277–300. doi: 10.3322/caac.20073.
3. Krebs in Deutschland 2009/2010. 9. Auflage. Robert Koch
-Institut (Hrsg.) und die Gesellschaft der epidemiologischen 
Krebsregister in Deutschland e.V. (Hrsg). Berlin 2013. http:// 
//www.gekid.de/Doc/krebs_in_Deutschland_2009_2010.pdf.
4. Laohavinij S, Maneechavakajorn J, Techatanol P. Prognosis 
factors for the survival in colorectal cancer patients. J Med 
Assoc Thai. 2010;93:1156–1166. PMID: 15516006.
5. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO 
Classification of tumours of the digestive system. 4th edition. 
Lyon; 2010.
6. Morson B. The Polyp-Cancer-Sequence in the Large Bowel. 
Section of Proctology, 1974, Volume 67 (St. Mark’s Hospital, 
City Road, London ECL, UK). PMID: 4853754.
7. Neri E, Faggioni L, Cini L, Bartolozzi C. Colonic polyps: 
inheritance, susceptibility, risk evaluation and diagnostic 
management. Cancer Manag Res. 2010;3:17–24. doi: 10.2147/ 
/CMR.S15705.
8. Morson BC, Jass JR. Precancerous lesions of the gastrointe-
stinal tract. A histological classification. London: Bailliere- 
-Tindall; 1985.
9. Goh HS, Jass JR. DNA content and the adenoma-carcinoma 
sequence in the colorectum. J Clin Pathol. 1986;39:387–392. 
doi: 10.1136/jcp.39.4.387.
10. Konishi F, Morson BC. Pathology of colorectal adenomas: 
a colonoscopic survey. J Clin Pathol. 1982;35:830–841. doi: 
10.1136/jcp.35.8.830.
11. Quirke P, Fozard JB, Dixon MF, Dyson JE, Giles GR, Bird CC. 
DNA aneuploidy in colorectal adenomas. Br J Cancer. 
1986;53:477–481. PMID: 3707842.
12. Sedivy R, Wolf B, Kalipciyan M, Steger GG, Kerner-Ha-
nunsch J, Mader RM. Genetic analysis of multiple synchro-
nous lesions of the colon adenoma-carcinoma sequence. Br 
J Cancer. 2000;82:1278–1282. doi: 10.1054/bjoc.1999.1091.
13. Weinberg RA. The Biology of Cancer. Baltimore: Garland 
Science; 2006.
14. Sieber OM, Heinimann K, Tomlinson IP. Genomic instability 
— the engine of tumorigenesis? Nat Rev Cancer. 2003;3:701–
–708. doi: 10.1038/nrc1170.
15. Fearon E, Vogelstein B. A Genetic model for colorectal 
tumorigenesis. Cell. 1990;61:759–767. doi: 10.1016/0092- 
-8674(90)90186-I.
16. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, 
Diaz LA, Kinzler KW. Cancer genome landscapes. Science. 
2013;339:1546–1558. doi: 10.1126/science.1235122.
17. Walther B, Walther I, Chen Y, Petersen I. GNAS1 muta-
tions in gastrointestinal tumors. Folia Histochem Cytobiol. 
2014;52:90–95. doi: 10.5603/FHC.2014.0011.
18. Smith G, Carey FA, Beattie J et al. Mutation in APC, Kir-
sten-ras and P53 — alternative genetic pathway to colorectal 
cancer. Proc Natl Acad Sci. 2002;99:9433–9438. doi: 10.1073/ 
/pnas.122612899.
19. Beckman RA, Loeb LA. Genetic instability in cancer: theory 
and experiment. Semin Cancer Biol. 2005;15:423–435. doi: 
10.1016/j.semcancer.2005.06.007.
20. Vielh P, Magdelenat H, Remvikos Y, Dutrillaux B. Analysis 
of DNA content. In: Flow cytometry. 1st ed. New York: Iga-
ku–Shoin; 1991;21–27.
21. Weaver BA, Cleveland DW. Does aneuploidy cause cancer? 
Curr Opin Cell Biol. 2006;18:658–667. doi: 10.1016/j.ceb. 
2006.10.002.
22. Baretta A, Marzullo F, Pellecchia A et al. DNA flow cyto-
metry, p53 levels and proliferative cell nuclear antigen in 
human colon dysplastic, precancerous and cancerous tissues. 
Anticancer Res. 1998;18:1677–1682. PMID: 9673389.
23. Löfberg R, Caspersson T, Tribukait B, Ost A. Comparative 
DNA analyses in longstanding ulcerative colitis with ane-
uploidy. Gut. 1989;30:1731–1736. doi: 10.1136/gut.30.12.1731. 
24. Petersen I, Kotb WF, Friedrich KH, Schlüns K, Böcking A, 
Dietel M. Core classification of lung cancer: Correlating nuc-
lear size and the mitosis with ploidy and clinicopathological 
parameters. Lung Cancer. 2009;5:312–318. doi: 10.1016/j.
lungcan.2008.12.013.
25. Kotb WF, Blind C, Friedrich KH et al. Core classification 
of head and neck squamous cell carcinomas: correlations 
between morphology, DNA ploidy and HPV infection. Pathol 
Res Pract. 2010;206:768–771. doi: 10.1016/j.prp.2010.07.011.
26. Praça-Fontes MM, Carvalho CR, Clarindo WR. C-value 
reassessment of plant standards: an image cytometry ap-
proach. Plant Cell Rep. 2011;30:2303–2312. doi: 10.1007/ 
/s00299-011-1135-6.
27. Habermann JK, Brucker CA, Freitag-Wolf S et al. Genomic 
instability and oncogene amplifications in colorectal adeno-
mas predict recurrence and synchronous carcinoma. Mod 
Pathol. 2011;24:542–555. doi: 10.1038/Modpathol.2010.217. 
28. Araujo SE, Bernardo WM, Habr-Gama A, Kiss DR, Cec-
conello I. DNA ploidy status and prognosis in colorectal 
cancer: a meta-analysis of published data. Dis Colon Rectum. 
2007;50:1800–1810. PMID: 17874166.
29. Knösel T, Petersen S, Schwabe H et al. Incidence of chro-
mosomal imbalances in advanced colorectal carcinomas and 
their metastases. Virchows Arch. 2002;440:187–194. PMID: 
11964050.
30. Knösel T, Schlüns K, Stein U et al. Chromosomal alterations 
during lymphatic and liver metastasis formation of colorectal 
cancer. Neoplasia. 2014;6:23–38. PMID: 15068668.
31. Brosens RP, Belt EJ, Haan JC et al. Deletion of chromosome 
4q predicts outcome in stage II colon cancer patients. Anal Cell 
Pathol. 2010;33:95–104. doi: 10.3233/ACP-CLO-2010-0531.
32. Ried T, Knutzen R, Steinbeck R et al. Comparative Genomic 
Hybridization reveals a specific pattern of chromosomal gains 
and losses during the genesis of colorectal tumors. Genes, 
Chromosomes Cancer. 1996;15:234–245. PMID: 8703849.
33. Schulze S, Petersen I. Gender and ploidy in cancer survival. 
Cell Oncol (Dordr). 2011;34:199–208. doi: 10.1007/s13402- 
-011-0013-0.
34. Amin Kotb WFM, Petersen I. Morphology, DNA ploidy and 
HPV in lung cancer and head and neck cancer. Pathol Res 
Pract. 2012;208:1–8. doi: 10.1016/j.prp.2011.10.009.
35. Steinbeck RG, Heselmeyer KM, Auer GU. DNA ploidy 
in human colorectal adenomas. Anal Quant Cytol Histol. 
1994;16:196–202. PMID: 7916847.
36. Joergensen MW, Niemann I, Rasmussen AA et al. Triploid 
pregnancies: genetic and clinical features of 158 cases. Am 
 J Obstet Gyncecol. 2014;211:370.e1–e19. doi: 10.1016/j.ajog. 
2014.03.039. 
37. Hanahan D, Weinberg RA. Hallmarks of cancer: The 
next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell. 
2011.02.013.
38. Rajkumar SV. Multiple myeloma: 2011 update on diagno-
sis, risk-stratification, and management. Am J Hematol. 
2011;86:57–65. doi: 10.1002/ajh.21913.
39. Harrison CJ, Moorman AV, Broadfield ZJ et al. Three 
distinct subgroups of hypodiploidy in acute lymphoblastic 
leukaemia. Br J Haematol. 2004;125:552–559. doi: 10.1111/j.
1365-2141.2004.04948.x.
18 Judith Staarmann et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2015
10.5603/FHC.a2015.0001
www.fhc.viamedica.pl
40. Moorman AV, Harrison CJ, Buck GA et al. Karyotype is an 
independent prognostic factor in adult acute lymphoblastic 
leukemia (ALL): analysis if cytogenetic data from patients tre-
ated on the Medical Research Council (MRC) UKALLXII/ 
/Eastern Cooperative Oncology Group (ECOG) 2993 trial. 
Blood. 2007;109:3189–3197. doi: 10.1182/blood-2006-10-051912.
41. Atkin NB. Frequency of hyperdiploid chromosome comple-
ments in endometrioid tumor of the endometrium whereas 
similar tumors in the ovary tend to show hypodiploidy: 
a significant difference that may not be distinguishable by 
flow cytometry of DNA content. Cytogenet Genome Res. 
2002;97:39–42. doi: 10.1159/000064053.
42. Pera F, Rainer B. Studies of multipolar mitoses in euploid 
tissue cultures. I. Somatic reduction to exactly haploid and 
triploid chromosome sets. Chromosoma. 1973;42:71–86. 
PMID: 4123256.
43. Duncan AW, Taylor MH, Hickey RD et al. The ploidy con- 
veyor of mature hepatocytes as a source of genetic variation. 
Nature. 2010;467:707–710. doi: 10.1038/nature09414.
44. Duncan AW, Hanlon Newell AE et al. Frequent aneuplo-
idy among normal human hepatocytes. Gastroenterology. 
2012;142:25–28. doi: 10.1053/j.gastro.2011.10.029.
45. Duncan AW. Aneuploidy, polyploidy and ploidy reversal in 
the liver. Semin Cell Dev Biol. 2013;24:347–356. doi: 10.1016/j.
semcdb.2013.01.003.
46. Bazeley PS, Nestor Kalinoski AL et al. A model for random 
genetic damage directing selection of diploid or aneuploid 
tumours. Cell Prolif. 2011;44:212–223. doi: 10.1111/j.
1365-2184.2011.00746.x. 
47. Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuplo-
idy and cancer. Curr Opin Genet Dev. 2007;17:157–162. doi: 
10.1016/j.gde.2007.02.011.
48. Holland AJ, Cleveland DW. Losing balance: the origin and 
impact of aneuploidy in cancer. EMBO Rep. 2012;13:501–514. 
doi: 10.1038/embor.2012.55. 
49. Krämer A, Maier B, Bartek J. Centrosome clustering 
and chromosomal (in)stability: a matter of life and death. 
Mol Oncol. 2011;5:324–335. doi: 10.1016/j.molonc.2011.05.003. 
Submitted: 10 August, 2014 
Accepted after reviews: 5 February, 2015 
Available as AoP: 13 February, 2015
